Abstract
Introduction
The COVID-19 pandemic has caused unprecedented pressure on medical care resources and access. The aim of this study was to evaluate the time between the cancer symptoms’ onset and the first ENT specialist consultation for patients with head and neck (HNC) and salivary glands cancers during the pandemic.
Methods
The outcome measures evaluated were time to diagnosis, and time to treatment onset, as well as the COVID-19 impact on the proportion of both cancer patient groups: asymptomatic and advanced stages. This is single-centre retrospective cross-sectional study, including 473 patients who were treated in our University Hospital for HNC and salivary gland cancers, 171 in the COVID-19 pandemic group (C +), and 302 patients in the pre-pandemic group (C−).
Results
There were no significant between-group differences in the delays between cancer symptoms’ onset and ENT consultation, diagnostic workup and initial treatment onset, respectively. There was a suggestive reduction in the number of diagnostic panendoscopy performed in the C + group (62%) compared to the C- group (73%) as well as a suggestive increase in the delay to adjuvant radiotherapy onset.
Conclusion
The median delay between cancer symptoms’ onset and ENT specialist consultation was not affected by the COVID-19 pandemic in our centre. Our results suggest an 11% decrease in diagnostic procedures performed independently, a decrease in the delay between the ENT consultation and surgical treatment onset and a 10-day increase in the delay to adjuvant radiotherapy onset.
Similar content being viewed by others
Data availability
Data available on request.
References
Bray F, Ferlay J, Soerjomatan I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA J Clin 68:394–424. https://doi.org/10.3322/caac.21492
Graboyes EM, Kompelli AR, Neskey DM et al (2019) Association of treatment delays with survival for patients with head and neck cancer: a systematic review. JAMA Otolaryngol Head Neck Surg. 145(2):166–177. https://doi.org/10.1001/jamaoto.2018.2716
Dong E, Du H, Gardner L (2020) An interactive web-based dashboard to track Covid-19 in real time. Lancet Infect Dis 20(5):533–534. https://doi.org/10.1016/S1473-3099(20)30120-1
Fakhry N, Schultz P, Morinière S et al (2020) French consensus on management of head and neck cancer surgery during COVID-19 pandemic. Eur Ann Otorhinolaryngol Head Neck Dis 137(3):159–160. https://doi.org/10.1016/j.anorl.2020.04.008
Heimes D, Muller LK, Schellin A et al (2021) Consequences of the Covid-19 pandemic and governmental containment policies on the detection and therapy of oral malignant lesions-a retrospective, multicenter cohort study from Germany. Cancers 13(12):2892. https://doi.org/10.3390/cancers13122892
Peacock HM, Tambuyzer T, Verdoodt F et al (2021) Decline and incomplete recovery in cancer diagnoses during the Covid-19 pandemic in Belgium: a year-long, population-level analysis. Eur Soc Med Oncol 6(4):100197. https://doi.org/10.1016/j.esmoop.2021.100197
Sandhu P, Grossman S, Beneng K (2021) The impact of cessation of primal dental care services on oral cancer diagnosis at a single institution in the UK’s epicentre during the COVID-19 pandemic. Oral Surg 14(4):328–334. https://doi.org/10.1111/ors.12626
Paleri V, Hardman J, Tikka T et al (2020) Rapid implementation of an evidence-based remote triaging system for assessment of suspected referrals and patients with head and neck cancer on follow-up after treatment during the COVID-19 pandemic: model for international collaboration. Head Neck 42(7):1674–1680. https://doi.org/10.1002/hed.26219
Singh AK, Kasle DA, Jiang R et al (2020) A review of telemedicine, applications in otorhinolaryngology: considerations during the coronavirus disease of 2019 pandemic. Laryngoscope 131(4):744–759. https://doi.org/10.1002/lary.29131
Mehanna H, Hardman JC, Shenson JA et al (2020) Recommendations for head and neck surgical oncology practice in a setting of acute severe resource constraint during the COVID-19 pandemic: an international consensus. The lancet 21(7):350–359. https://doi.org/10.1016/S1470-2045(20)30334-X
Murphy CT, Galloway TJ, Handorf EA et al (2015) Survival impact of increasing time to treatment initiation for patients with head and neck cancer in the United States. J Clin Oncol 34(2):169–178. https://doi.org/10.1200/JCO.2015.61.5906
Rygalski CJ, Zhao S, Eskander A et al (2021) Time to surgery and survival in head and neck cancer. Ann Surg Oncol 28(2):877–885. https://doi.org/10.1245/s10434-020-09326-4
Von Elm E, Altman DG, Egger M et al (2008) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370(9596):1453–1457. https://doi.org/10.1016/S0140-6736(07)61602-X
Ionannidis JPA (2018) The proposal to lower P value thresholds to .005. JAMA. 319(14):1429–1430. https://doi.org/10.1001/jama.2018.1536
Laccourreye O, Fakhry N, Franco-Vidal V et al (2020) Statistics in scientific articles published in the European Annals of Otorhinolaryngology Head and Neck Diseases, European Annals of Otorhinolaryngology. Head and Neck diseases 138(2):89–92. https://doi.org/10.1016/j.anorl.2020.06.015
Stevens MN, Patro A, Rashman B et al (2022) Impact of COVID-19 on presentation, staging and treatment of head and neck mucosal squamous cell carcinoma. Am J Otorhinolaryngol-Head Neck Med Surg 43(1):103263. https://doi.org/10.1016/j.amjoto.2021.103263
Tan H, Preston J, Hunn S et al (2021) COVID-19 did not delay time from referral to definitive management for head and neck cancer patients in a regional Victorian center. ANZ J Surg 91(7–8):1364–1368. https://doi.org/10.1111/ans.17057
Tevetoglu F, Kara S, Aliyeva C et al (2021) Delayed presentation of head and neck cancer patients during COVID-19 pandemic. Eur Arch Otorhinolaryngol 278(12):5081–5085. https://doi.org/10.1007/s00405-021-06728-2
Metzger K, Mrosek J, Zittel S et al (2021) Treatment delay and tumor size in patients with oral cancer during the first year of the COVID-19 pandemic. Head Neck 43(11):3493–3497. https://doi.org/10.1002/hed.26858
Laccourreye O, Mirghani H, Evrard D et al (2020) Impact of the first month of Covid-19 lockdown on oncologic surgical activity in the Ile de France region university hospital otorhinolaryngology departments. Eur Ann Otolaryngol Head Neck Dis 137(4):273–276. https://doi.org/10.1016/j.anorl.2020.06.007
Kiong KL, Diaz EM, Gross ND et al (2021) The impact of COVID-19 on head and neck cancer diagnosis and disease extent. Head Neck 43(6):1890–1897. https://doi.org/10.1002/hed.26665
Ruiz-Medina S, Gil S, Jimenez B et al (2021) Significant decrease in annual cancer diagnoses in Spain during the COVID-19 pandemic: a real-data study. Cancers 13(13):3215. https://doi.org/10.3390/cancers13133215
Taylor R, Omakobia E, Sood S et al (2020) The impact of coronavirus disease 2019 on head and neck cancer services: a UK tertiary center study. J Laryngol Otol 134(8):684–687. https://doi.org/10.1017/S0022215120001735
De Luca P, Bisogno A, Colacurcio V et al (2022) Diagnosis and treatment delay of head and neck cancers during COVID-19 era in a tertiary care academic hospital: what should we expect? Eur Arch Otorhinolaryngol 279(2):961–965. https://doi.org/10.1007/s00405-021-06834-1
Hale T, Angrist N, Goldszmidt R et al (2021) A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker). Nat Hum Behav 5(4):529–538. https://doi.org/10.1038/s41562-021-01079-8
Acknowledgements
The authors thank Dr Clodic Coralie for the study project.
Funding
No funding was provided for this study.
Author information
Authors and Affiliations
Contributions
MC, CC and AS: for data collection, MR and LJC: for the statistical analysis, MC: for the writing process and ZA: for data interpretation and intellectual content editing.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Ethical approval
This study was approved by the Institutional Ethics Committee (Brest Ethics Committee) (protocol number 29BRC21.0372). The research was conducted ethically, with all study procedures being performed in accordance with the requirements of the World Medical Association’s Declaration of Helsinki.
Informed consent
Written informed consent was obtained from each participant/patient for study participation and data publication.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Clementine, M., Camille, C., Swann, A. et al. COVID-19 impact on the management of head and neck cancer: a French single-centre experience. Eur Arch Otorhinolaryngol 281, 873–882 (2024). https://doi.org/10.1007/s00405-023-08245-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-023-08245-w